165 related articles for article (PubMed ID: 27110040)
21. NADH:Cytochrome b5 Reductase and Cytochrome b5 Can Act as Sole Electron Donors to Human Cytochrome P450 1A1-Mediated Oxidation and DNA Adduct Formation by Benzo[a]pyrene.
Stiborová M; Indra R; Moserová M; Frei E; Schmeiser HH; Kopka K; Phillips DH; Arlt VM
Chem Res Toxicol; 2016 Aug; 29(8):1325-34. PubMed ID: 27404282
[TBL] [Abstract][Full Text] [Related]
22. The anticancer drug ellipticine activated with cytochrome P450 mediates DNA damage determining its pharmacological efficiencies: studies with rats, Hepatic Cytochrome P450 Reductase Null (HRN™) mice and pure enzymes.
Stiborová M; Černá V; Moserová M; Mrízová I; Arlt VM; Frei E
Int J Mol Sci; 2014 Dec; 16(1):284-306. PubMed ID: 25547492
[TBL] [Abstract][Full Text] [Related]
23. Comparison of human cytochrome P450 1A1-catalysed oxidation of benzo[
Stiborová M; Indra R; Moserová M; Bořek-Dohalská L; Hodek P; Frei E; Kopka K; Schmeiser HH; Arlt VM
Monatsh Chem; 2017; 148(11):1959-1969. PubMed ID: 29104317
[TBL] [Abstract][Full Text] [Related]
24. The anticancer drug ellipticine is a potent inducer of rat cytochromes P450 1A1 and 1A2, thereby modulating its own metabolism.
Aimová D; Svobodová L; Kotrbová V; Mrázová B; Hodek P; Hudecek J; Václavíková R; Frei E; Stiborová M
Drug Metab Dispos; 2007 Oct; 35(10):1926-34. PubMed ID: 17656468
[TBL] [Abstract][Full Text] [Related]
25. beta-Naphthoflavone-inducible cytochrome P4501A1 activity in liver microsomes of the marine safi fish (Siganus canaliculatus).
Raza H; Otaiba A; Montague W
Biochem Pharmacol; 1995 Oct; 50(9):1401-6. PubMed ID: 7503790
[TBL] [Abstract][Full Text] [Related]
26. Modulation of CYP1A1-mediated oxidation of carcinogenic azo dye Sudan I and its binding to DNA by cytochrome b5.
Stiborová M; Martínek V; Schmeiser HH; Frei E
Neuro Endocrinol Lett; 2006 Dec; 27 Suppl 2():35-9. PubMed ID: 17159775
[TBL] [Abstract][Full Text] [Related]
27. Expression of cytochrome P450 1A1 and its contribution to oxidation of a potential human carcinogen 1-phenylazo-2-naphthol (Sudan I) in human livers.
Stiborová M; Martínek V; Rýdlová H; Koblas T; Hodek P
Cancer Lett; 2005 Apr; 220(2):145-54. PubMed ID: 15766589
[TBL] [Abstract][Full Text] [Related]
28. Heterologous expression of human cytochrome P450 2S1 in
Mrízová I; Moserová M; Milichovský J; Šulc M; Kizek R; Kubáčková K; Arlt VM; Stiborová M
Monatsh Chem; 2016; 147():881-888. PubMed ID: 27110039
[TBL] [Abstract][Full Text] [Related]
29. Enhanced DNA adduct formation by benzo[a]pyrene in human liver cells lacking cytochrome P450 oxidoreductase.
Reed L; Jarvis IWH; Phillips DH; Arlt VM
Mutat Res Genet Toxicol Environ Mutagen; 2020 Apr; 852():503162. PubMed ID: 32265041
[TBL] [Abstract][Full Text] [Related]
30. Enzymes oxidizing the azo dye 1-phenylazo-2-naphthol (Sudan I) and their contribution to its genotoxicity and carcinogenicity.
Stiborova M; Schmeiser HH; Frei E; Hodek P; Martinek V
Curr Drug Metab; 2014; 15(8):829-40. PubMed ID: 25658126
[TBL] [Abstract][Full Text] [Related]
31. Exposure to benzo[a]pyrene of Hepatic Cytochrome P450 Reductase Null (HRN) and P450 Reductase Conditional Null (RCN) mice: Detection of benzo[a]pyrene diol epoxide-DNA adducts by immunohistochemistry and 32P-postlabelling.
Arlt VM; Poirier MC; Sykes SE; John K; Moserova M; Stiborova M; Wolf CR; Henderson CJ; Phillips DH
Toxicol Lett; 2012 Sep; 213(2):160-6. PubMed ID: 22759596
[TBL] [Abstract][Full Text] [Related]
32. Exposure of rats to exogenous endocrine disruptors 17alpha-ethinylestradiol and benzo(a)pyrene and an estrogenic hormone estradiol induces expression of cytochromes P450 involved in their metabolism.
Borek-Dohalska L; Klusonova Z; Holecova J; Martinkova M; Barta F; Dracinska H; Cajthaml T; Stiborova M
Neuro Endocrinol Lett; 2016 Dec; 37(Suppl1):84-94. PubMed ID: 28263535
[TBL] [Abstract][Full Text] [Related]
33. Role of hepatic cytochromes P450 in bioactivation of the anticancer drug ellipticine: studies with the hepatic NADPH:cytochrome P450 reductase null mouse.
Stiborová M; Arlt VM; Henderson CJ; Wolf CR; Kotrbová V; Moserová M; Hudecek J; Phillips DH; Frei E
Toxicol Appl Pharmacol; 2008 Feb; 226(3):318-27. PubMed ID: 17976674
[TBL] [Abstract][Full Text] [Related]
34. Induction of liver microsomal cytochrome P450 in cynomolgus monkeys.
Bullock P; Pearce R; Draper A; Podval J; Bracken W; Veltman J; Thomas P; Parkinson A
Drug Metab Dispos; 1995 Jul; 23(7):736-48. PubMed ID: 7587963
[TBL] [Abstract][Full Text] [Related]
35. Tyrosine kinase inhibitors vandetanib, lenvatinib and cabozantinib modulate oxidation of an anticancer agent ellipticine catalyzed by cytochromes P450 in vitro.
Kolarik M; Indra R; Adam V; Heger Z; Kopeckova K; Arlt VM; Stiborova M
Neuro Endocrinol Lett; 2019 Feb; 39(7):515-524. PubMed ID: 30860683
[TBL] [Abstract][Full Text] [Related]
36. Qualitative and quantitative differences in the induction and inhibition of hepatic benzo[a]pyrene metabolism in the rat and hamster.
Wroblewski VJ; Gessner T; Olson JR
Biochem Pharmacol; 1988 Apr; 37(8):1509-17. PubMed ID: 3358781
[TBL] [Abstract][Full Text] [Related]
37. 3-aminobenzanthrone, a human metabolite of the environmental pollutant 3-nitrobenzanthrone, forms DNA adducts after metabolic activation by human and rat liver microsomes: evidence for activation by cytochrome P450 1A1 and P450 1A2.
Arlt VM; Hewer A; Sorg BL; Schmeiser HH; Phillips DH; Stiborova M
Chem Res Toxicol; 2004 Aug; 17(8):1092-101. PubMed ID: 15310241
[TBL] [Abstract][Full Text] [Related]
38. Anticancer agent ellipticine combined with histone deacetylase inhibitors, valproic acid and trichostatin A, is an effective DNA damage strategy in human neuroblastoma.
Poljakova J; Hrebackova J; Dvorakova M; Moserova M; Eckschlager T; Hrabeta J; Göttlicherova M; Kopejtkova B; Frei E; Kizek R; Stiborova M
Neuro Endocrinol Lett; 2011; 32 Suppl 1():101-16. PubMed ID: 22167207
[TBL] [Abstract][Full Text] [Related]
39. Characterization of microsomal cytochrome P450 enzymes involved in the oxidation of xenobiotic chemicals in human fetal liver and adult lungs.
Shimada T; Yamazaki H; Mimura M; Wakamiya N; Ueng YF; Guengerich FP; Inui Y
Drug Metab Dispos; 1996 May; 24(5):515-22. PubMed ID: 8723730
[TBL] [Abstract][Full Text] [Related]
40. Cytochromes P450 reconstituted with NADPH: P450 reductase mimic the activating and detoxicating metabolism of the anticancer drug ellipticine in microsomes.
Kotrbová V; Aimová D; Brezinová A; Janouchová K; Poljaková J; Frei E; Stiborová M
Neuro Endocrinol Lett; 2006 Dec; 27 Suppl 2():18-22. PubMed ID: 17159771
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
